163 related articles for article (PubMed ID: 11472397)
1. Identification of antigenic domains on the human sodium-iodide symporter which are recognized by autoantibodies from patients with autoimmune thyroid disease.
Kemp EH; Waterman EA; Ajjan RA; Smith KA; Watson PF; Ludgate ME; Weetman AP
Clin Exp Immunol; 2001 Jun; 124(3):377-85. PubMed ID: 11472397
[TBL] [Abstract][Full Text] [Related]
2. Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease.
Ajjan RA; Kemp EH; Waterman EA; Watson PF; Endo T; Onaya T; Weetman AP
J Clin Endocrinol Metab; 2000 May; 85(5):2020-7. PubMed ID: 10843191
[TBL] [Abstract][Full Text] [Related]
3. Low frequency of autoantibodies to the human Na(+)/I(-) symporter in patients with autoimmune thyroid disease.
Seissler J; Wagner S; Schott M; Lettmann M; Feldkamp J; Scherbaum WA; Morgenthaler NG
J Clin Endocrinol Metab; 2000 Dec; 85(12):4630-4. PubMed ID: 11134119
[TBL] [Abstract][Full Text] [Related]
4. Binding of immunoglobulin G from patients with autoimmune thyroid disease to rat sodium-iodide symporter peptides: evidence for the iodide transporter as an autoantigen.
Morris JC; Bergert ER; Bryant WP
Thyroid; 1997 Aug; 7(4):527-34. PubMed ID: 9292938
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells.
Tonacchera M; Agretti P; Ceccarini G; Lenza R; Refetoff S; Santini F; Pinchera A; Chiovato L; Vitti P
Eur J Endocrinol; 2001 Jun; 144(6):611-8. PubMed ID: 11375795
[TBL] [Abstract][Full Text] [Related]
6. The immune response to the iodide transporter.
Spitzweg C; Morris JC
Endocrinol Metab Clin North Am; 2000 Jun; 29(2):389-98, viii. PubMed ID: 10874536
[TBL] [Abstract][Full Text] [Related]
7. [Autoantibody against Na+/I- symporter (NaIS)].
Zeki K
Nihon Rinsho; 1999 Aug; 57(8):1824-8. PubMed ID: 10483259
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody against Na+/I- symporter in the sera of patients with autoimmune thyroid disease.
Endo T; Kogai T; Nakazato M; Saito T; Kaneshige M; Onaya T
Biochem Biophys Res Commun; 1996 Jul; 224(1):92-5. PubMed ID: 8694839
[TBL] [Abstract][Full Text] [Related]
9. Analysis of human sodium/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases.
Joba W; Spitzweg C; Schriever K; Heufelder AE
Thyroid; 1999 May; 9(5):455-66. PubMed ID: 10365677
[TBL] [Abstract][Full Text] [Related]
10. Rarity of anti- Na+/I- symporter (NIS) antibody with iodide uptake inhibiting activity in autoimmune thyroid diseases (AITD).
Chin HS; Chin DK; Morgenthaler NG; Vassart G; Costagliola S
J Clin Endocrinol Metab; 2000 Oct; 85(10):3937-40. PubMed ID: 11061560
[TBL] [Abstract][Full Text] [Related]
11. The modulation of the human sodium iodide symporter activity by Graves' disease sera.
Ajjan RA; Findlay C; Metcalfe RA; Watson PF; Crisp M; Ludgate M; Weetman AP
J Clin Endocrinol Metab; 1998 Apr; 83(4):1217-21. PubMed ID: 9543144
[TBL] [Abstract][Full Text] [Related]
12. B-cell autoepitopes on the acetylcholinesterase-homologous region of human thyroglobulin: association with Graves' disease and thyroid eye disease.
Thrasyvoulides A; Sakarellos-Daitsiotis M; Philippou G; Souvatzoglou A; Sakarellos C; Lymberi P
Eur J Endocrinol; 2001 Aug; 145(2):119-27. PubMed ID: 11454506
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies in vitiligo patients recognize multiple domains of the melanin-concentrating hormone receptor.
Gottumukkala RV; Waterman EA; Herd LM; Gawkrodger DJ; Watson PF; Weetman AP; Kemp EH
J Invest Dermatol; 2003 Oct; 121(4):765-70. PubMed ID: 14632194
[TBL] [Abstract][Full Text] [Related]
14. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
[TBL] [Abstract][Full Text] [Related]
15. Molecular mapping of epitopes on melanocyte-specific protein Pmel17 which are recognized by autoantibodies in patients with vitiligo.
Kemp EH; Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP
Clin Exp Immunol; 2001 Jun; 124(3):509-15. PubMed ID: 11472416
[TBL] [Abstract][Full Text] [Related]
16. Anti-natrium/iodide symporter antibodies and other anti-thyroid antibodies in children with Turner's syndrome.
Kucharska AM; Czarnocka B; Demkow U
Adv Exp Med Biol; 2013; 756():131-8. PubMed ID: 22836628
[TBL] [Abstract][Full Text] [Related]
17. Autoimmunity involving the human sodium/iodide symporter: fact or fiction?
Heufelder AE; Joba W; Morgenthaler NG
Exp Clin Endocrinol Diabetes; 2001; 109(1):35-40. PubMed ID: 11573137
[TBL] [Abstract][Full Text] [Related]
18. Thyroperoxidase, thyroglobulin, Na(+)/I(-) symporter, pendrin in thyroid autoimmunity.
Czarnocka B
Front Biosci (Landmark Ed); 2011 Jan; 16(2):783-802. PubMed ID: 21196203
[TBL] [Abstract][Full Text] [Related]
19. The sodium iodide symporter is unlikely to be a thyroid/breast shared antigen.
Muller I; Zhang L; Giani C; Dayan CM; Ludgate ME; Grennan-Jones F
J Endocrinol Invest; 2016 Mar; 39(3):323-31. PubMed ID: 26253711
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of autoantibodies against thyroid peroxidase in autoimmune thyroid disease: evidence against antibodies directly inhibiting peroxidase activity as regulatory factors in thyroid hormone metabolism.
Saller B; Hörmann R; Mann K
J Clin Endocrinol Metab; 1991 Jan; 72(1):188-95. PubMed ID: 1702446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
